420 with CNW — Congressional Committee Begins Investigation into Inaction by the FDA on CBD Regulation
The House Oversight and Accountability Committee Chair recently penned a letter to the FDA, notifying the agency that an investigation into its decision to not regulate CBD was being conducted. CBD (cannabidiol) is one of the two main compounds found in cannabis, the other being THC. Unlike THC, however, CBD doesn’t induce a high when consumed. This compound, which is derived from hemp, is also not addictive. Representative James Comer criticized the agency’s inaction on the matter, stating in his letter that CBD was a popular product whose use had risen in the last few years. In January 2023, the…